Zinnat 125 mg/5 ml, 100 ml granules for suspension

Zinnat Composition:
active ingredient: cefuroxime; 5 ml of the finished suspension in a vial contains cefuroxime (in the form of cefuroxime axetil) 125 mg; excipients: povidone K30, stearic acid, sucrose, fruit flavor, aspartame (E 951), xanthan gum, acesulfame potassium.

Pharmacotherapeutic group:
Antimicrobial agents for systemic use. Beta-lactam antibiotics. ATX code J01D C02.

Indications:
Zinnat is indicated for the treatment of the infections listed below in adults and children over 3 months of age: Acute streptococcal tonsillitis and pharyngitis. Acute bacterial sinusitis. Acute otitis media. Exacerbation of chronic bronchitis caused by pathogens sensitive to cefuroxime axetil. Cystitis. Pyelonephritis. Uncomplicated skin and soft tissue infections. Early manifestations of Lyme disease.

Produced in United Kingdom